Skip to content
AnalystLens

Merck Annual Report (Amendment), Year Ended Dec 31, 1995

Filing Date
Filed June 14, 1996
Period End
December 31, 1995
Security
MRK
In the record · 2016–202610-K1210-Q338-K87

MRK filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 87 current reports (8-K) between 2016 and 2026.

  1. Impairment8-K · Feb ’17Feb ’17
  2. Restructuring8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Restructuring8-K · Jul ’25Jul ’25

Summary

Summary of the 10-K/A filed June 14, 1996. Cited figures are marked; the original filing is the authoritative source.

The filing excerpt provided does not support the requested analysis.

It is labeled as Form 10-K/A, Amendment No. 1, and names Schering-Plough Corporation as the registrant, not Merck & Co., Inc. (MRK) as the request states. The excerpt contains only the SEC cover-page header and no financial statements, business description, risk factors, MD&A, or other substantive content, so no financial performance, revenue, earnings, pipeline, or balance-sheet conclusions can be drawn from it. Before any investor-facing analysis is prepared, the correct filing should be retrieved from EDGAR, confirming the registrant name, CIK, form type, and filing date (June 14, 1996).

If the intended company is Merck, its own 10-K for the relevant fiscal year should be used. If the Schering-Plough amendment is the intended document, the full text, including the amended sections, should be supplied so the analysis can be completed.

Key Highlights

  1. The provided document is a Form 10-K/A (Amendment No. 1), not an original 10-K annual report.
  2. The registrant named on the cover page is Schering-Plough Corporation, which does not match the requested company, Merck & Co., Inc. (MRK).
  3. The excerpt contains only the cover-page header; no financial data, operating results, or business disclosures are included.
  4. Because the amendment is incomplete in this excerpt, the sections it revises cannot be identified.
  5. The company and filing should be verified against EDGAR (filing date June 14, 1996) before any investment conclusions are drawn.

Frequently Asked Questions

  1. Is this document the Merck & Co. (MRK) 10-K filed June 14, 1996?

    No. The excerpt identifies the registrant as Schering-Plough Corporation and the form as a 10-K/A amendment. It should not be used as a source for Merck's financial results.

  2. What financial results does this filing report?

    None are present in the excerpt. It contains only the cover-page header, so revenue, net income, EPS, cash flow, and balance-sheet figures cannot be determined from it.

  3. Why would a 10-K/A be filed, and what might it change?

    A 10-K/A is typically filed to correct or supplement an original annual report, such as restating financial data, adding omitted exhibits or information, or fixing errors. The excerpt does not state which sections were amended, so the purpose cannot be determined from it.

  4. How should an investor proceed?

    Retrieve the correct filing from the SEC's EDGAR database, verify the registrant and form type, and review the complete document, including the financial statements and notes. If the user intends to analyze Merck, obtain Merck's 10-K for the relevant fiscal year. If Schering-Plough is the intended company, provide the full amended text.